l failure.
4. People do not all develop the same immune response
Even when two people receive the same vaccine, their immune responses may differ.
Age is one factor. The immune system changes throughout life, and older adults may respond differently to vaccination than younger adults. Some people also have conditions or receive treatments that weaken immune function.
For example, certain cancer treatments, organ-transplant medications, and other immunosuppressive therapies can interfere with the body’s ability to develop or maintain a strong response. People living with particular chronic conditions may also face a higher risk of severe illness if they become infected.
The US Centers for Disease Control and Prevention identifies older adults, people with certain medical conditions, people with weakened immune systems, and pregnant women among groups that can face increased risk from severe respiratory illness. Individual risk depends on the person’s circumstances.
These differences matter when interpreting breakthrough infections. A person whose immune response is weakened may have less protection than another person who received the same vaccine. That does not mean vaccination has no value for people with weakened immune systems; rather, it means their protection and preventive needs may require individual assessment by a healthcare professional.
5. Previous infection and vaccination create different layers of immunity
Some people have been vaccinated but never had COVID-19. Others have experienced one or more infections before or after vaccination. Their immune histories are not identical.
Immunity developed through vaccination and immunity developed after infection can both contribute to the body’s ability to recognize SARS-CoV-2. When a person has both, the resulting protection is often called hybrid immunity.
The strength and duration of that protection vary, and neither previous infection nor vaccination guarantees that a person will never become infected again. Infection itself can also lead to complications, including prolonged symptoms, so deliberately seeking infection is not a safe substitute for prevention.
The WHO notes that hybrid immunity can provide stronger protection against severe outcomes from future infections than infection alone. It also advises that people follow the vaccination recommendations of their national programmes, particularly when they belong to groups at elevated risk.
These layers of immunity help explain why two people exposed to the same variant may have different outcomes. One may have recent vaccination, a previous infection, or both; another may have more distant immune exposure. Age, health, and the intensity of exposure add further differences.
What Breakthrough Infection Really Means
The term breakthrough infection can sound alarming, especially when it appears in a headline. It simply describes an infection that occurs despite vaccination. The term does not automatically indicate that the illness is severe, that the vaccine has stopped working, or that the person will transmit the virus for a particular length of time.
A breakthrough infection can be asymptomatic, mildly symptomatic, or serious. Its outcome depends on many factors, including the person’s immune status, age, medical history, the virus involved, and the time since their last vaccination or infection.
The term also covers different situations that should not be confused with one another. A vaccinated person who tests positive without symptoms and a vaccinated person who requires hospital care both have breakthrough infections, but the clinical consequences are very different.
That is why the frequency of breakthrough infections alone is not a complete measure of vaccine performance. Researchers need to consider how often infections lead to severe disease and how those outcomes compare across appropriate groups.
A useful way to think about vaccine effectiveness is to separate several questions:
Does vaccination reduce the likelihood of becoming infected?
Does it reduce the likelihood of developing symptomatic illness?
Does it reduce the likelihood of hospitalization?
Does it reduce the likelihood of critical illness or death?
Does protection change with time, age, health status, or viral variant?
The answer to one question does not automatically determine the answer to the others.
Evidence reviewed by the WHO indicates that COVID-19 vaccines continue to provide protection against severe disease and death, even though they do not prevent every infection. A 2026 systematic review and meta-analysis also reported that vaccination reduced the risk of progression from symptomatic infection to hospitalization, while noting variation across age groups, study definitions, and variant periods.
The practical message is not that breakthrough infections should be ignored. They are important for public-health surveillance and for understanding how the virus changes. Rather, they should be interpreted in context.
If infections occur after vaccination, researchers need to ask whether the frequency and severity of those infections differ from what would be expected without vaccination. A single case cannot answer that question, and a headline describing one infection cannot substitute for population-level evidence.
Can Vaccinated People Still Spread COVID-19 to Others?
Yes. A person who has been vaccinated can still transmit SARS-CoV-2 if they become infected. Vaccination should therefore not be understood as a guarantee that someone cannot pass the virus to family members, coworkers, or other people.
However, transmission is not determined by vaccination status alone. It can be influenced by the amount of virus present, the stage of infection, the circulating variant, the person’s immune response, and the nature of their contact with others.
Some vaccinated people who develop COVID-19 may have a shorter period of detectable infectious virus or lower levels of virus than comparable unvaccinated people, but these patterns are not universal. The degree of protection against infection and transmission can also change as immunity wanes and new variants emerge.
This distinction is especially important when someone lives with a person who is older, immunocompromised, or otherwise at elevated risk of severe illness. Even if the vaccinated person expects to experience only mild symptoms, they may still expose someone else to the virus.
What should you do if you have symptoms?
If you develop symptoms consistent with COVID-19, such as a sore throat, cough, fever, fatigue, or congestion, consider the possibility of a respiratory infection even if you are vaccinated.
A practical approach includes the following:
Stay away from others while you feel unwell. This reduces the chance of passing an infection to other people.
Consider testing. A suitable COVID-19 test may help clarify whether SARS-CoV-2 is the cause. Follow the test instructions and local guidance about repeat testing when an initial result is negative but symptoms continue.
Improve ventilation. Fresh air and better airflow can reduce the concentration of infectious respiratory particles indoors.
Wear a well-fitting mask when appropriate. A mask can help reduce the spread of respiratory particles, especially when contact with other people cannot be avoided.
Take extra care around high-risk individuals. Avoid close contact with people who may be more vulnerable to serious complications while you are potentially infectious.
Seek medical advice promptly if you are at higher risk. Some COVID-19 treatments must be started within a limited period after symptoms begin.
The CDC advises people at increased risk who develop symptoms of a respiratory virus to seek healthcare promptly because testing and treatment may be time-sensitive.
These precautions do not mean vaccination has failed. They recognize that preventing every infection is difficult and that reducing transmission requires several layers of protection.
Why mild symptoms still deserve attention
